GIS vs TENX · P/E 8.2, rev $18.42B vs P/E 3.4, $24.1M cap
General Mills Inc (GIS) versus Tenax Therapeutics Inc (TENX) — a side-by-side from cached financials, not a winner call.
General Mills Inc (GIS) is a packaged foods company listed on NYSE.
Tenax Therapeutics Inc (TENX) is a biotechnology company listed on US.
Latest reported GIS revenue for 2026-05-31 was $18.42B. Net income was -$87.6M. Revenue was up 304.4% from 2025-05-25 to 2026-05-31. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
Latest reported TENX revenue for 2026-06-30 was $0. Net income was -$33.5M. TENX currently screens at market cap $24.1M and trailing P/E 3.4.
GIS currently screens at market cap $17.80B and trailing P/E 8.2. TENX currently screens at market cap $24.1M and trailing P/E 3.4.
Not investment advice. Open the GIS and TENX stock pages for the full models.
Not investment advice.